Skip to content

Clinical trials

Completed Precancerous Conditions trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Precancerous Conditions Status: Completed Clear all

145 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20007
20017
20027
20039
20049
200510
200610
200716
20087
200910
20103
20114
20125
20132
20142
20161
20173
20182
20191
20201
20212
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed145

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)10
AIDS Malignancy Consortium9
British Columbia Cancer Agency7
Alliance for Clinical Trials in Oncology5
M.D. Anderson Cancer Center5
Jonsson Comprehensive Cancer Center4
Northwestern University4
OHSU Knight Cancer Institute4
SWOG Cancer Research Network4
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Precancerous Conditions145
Lymphoma34
Leukemia32
Multiple Myeloma31
Monoclonal Gammopathy of Undetermined Significance30
Neoplasms, Plasma Cell30
Leukemia, Lymphocytic, Chronic, B-Cell29
Lymphoma, Follicular29
Lymphoma, Large B-Cell, Diffuse29
Lymphoma, Large-Cell, Immunoblastic29

Trials

Showing 26 to 50 of 145. Each trial links to its page on Pharma Observatory.

45 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.